An EGFR Targeted PET Imaging Probe for the Detection of Colonic Adenocarcinomas

News & Updates
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font.




- Jun 18, 2021
PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance


- Jun 18, 2021
18 F-FES PET/CT Measurement of ER Suppression during a Phase I Trial of GDC-0810


- Jun 15, 2021
A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68 Ga-DOTATOC


- Jun 15, 2021
Synthesis and preliminary PET imaging of of the ROS1/ALK inhibitor lorlatinib


- Jun 15, 2021
Specific 18F-FDHT Accumulation in Human Prostate Cancer Models Is Facilitated by Prebinding to SHBG


- Jun 15, 2021
Phage Display Selection, In Vitro Characterization, and Correlative PET Imaging of a HER3 Peptide


- Jun 15, 2021
Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance

- Jun 15, 2021
HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib


- Jun 15, 2021
HER3 Differentiates Basal From Claudin Type TNBC and Contributes to Drug Resistance


- Jun 14, 2021
Optical Imaging of MET for Enhanced Detection and Characterization of Hepatic Tumors


- Jun 13, 2021
Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions


- Jun 13, 2021
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader


- Jun 13, 2021
Free SSTR fraction predicts the antiproliferative effect of octreotide in NETs